December 25, 2015

ABMD update from 29 October

We are bullish on ABIOMED.


Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices.

Fair value: $106
Discount: 17%
Average yearly return: 41%
Outperformer.

The smart guy who jumped on the train when we drew your attention on 29 October made 32% gain and better HOLD the stock.

No comments:

Post a Comment